BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27999163)

  • 1. Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells.
    Kauffman RC; Bhuiyan TR; Nakajima R; Mayo-Smith LM; Rashu R; Hoq MR; Chowdhury F; Khan AI; Rahman A; Bhaumik SK; Harris L; O'Neal JT; Trost JF; Alam NH; Jasinskas A; Dotsey E; Kelly M; Charles RC; Xu P; Kováč P; Calderwood SB; Ryan ET; Felgner PL; Qadri F; Wrammert J; Harris JB
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.
    Aktar A; Rahman MA; Afrin S; Faruk MO; Uddin T; Akter A; Sami MIN; Yasmin T; Chowdhury F; Khan AI; Leung DT; LaRocque RC; Charles RC; Bhuiyan TR; Mandlik A; Kelly M; Kováč P; Xu P; Calderwood SB; Harris JB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2016 May; 23(5):427-435. PubMed ID: 27009211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of
    Kim D; Hong J; Choi Y; Han J; Kim S; Jo G; Yoon JY; Chae H; Yoon H; Lee C; Hong HJ
    J Microbiol Biotechnol; 2020 Nov; 30(11):1760-1768. PubMed ID: 32876069
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
    Villeneuve S; Boutonnier A; Mulard LA; Fournier JM
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.
    Aktar A; Rahman MA; Afrin S; Akter A; Uddin T; Yasmin T; Sami MIN; Dash P; Jahan SR; Chowdhury F; Khan AI; LaRocque RC; Charles RC; Bhuiyan TR; Mandlik A; Kelly M; Kováč P; Xu P; Calderwood SB; Harris JB; Qadri F; Ryan ET
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006399. PubMed ID: 29684006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility.
    Charles RC; Kelly M; Tam JM; Akter A; Hossain M; Islam K; Biswas R; Kamruzzaman M; Chowdhury F; Khan AI; Leung DT; Weil A; LaRocque RC; Bhuiyan TR; Rahman A; Mayo-Smith LM; Becker RL; Vyas JM; Faherty CS; Nickerson KP; Giffen S; Ritter AS; Waldor MK; Xu P; Kováč P; Calderwood SB; Kauffman RC; Wrammert J; Qadri F; Harris JB; Ryan ET
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
    Kaisar MH; Bhuiyan MS; Akter A; Saleem D; Iyer AS; Dash P; Hakim A; Chowdhury F; Khan AI; Calderwood SB; Harris JB; Ryan ET; Qadri F; Charles RC; Bhuiyan TR
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
    Losonsky GA; Tacket CO; Wasserman SS; Kaper JB; Levine MM
    Infect Immun; 1993 Feb; 61(2):729-33. PubMed ID: 8423098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
    Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.
    Johnson RA; Uddin T; Aktar A; Mohasin M; Alam MM; Chowdhury F; Harris JB; LaRocque RC; Bufano MK; Yu Y; Wu-Freeman Y; Leung DT; Sarracino D; Krastins B; Charles RC; Xu P; Kovác P; Calderwood SB; Qadri F; Ryan ET
    Clin Vaccine Immunol; 2012 Nov; 19(11):1712-21. PubMed ID: 22993410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of
    Kauffman RC; Adekunle O; Yu H; Cho A; Nyhoff LE; Kelly M; Harris JB; Bhuiyan TR; Qadri F; Calderwood SB; Charles RC; Ryan ET; Kong J; Wrammert J
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879588
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
    Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR
    Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh.
    Harris AM; Bhuiyan MS; Chowdhury F; Khan AI; Hossain A; Kendall EA; Rahman A; LaRocque RC; Wrammert J; Ryan ET; Qadri F; Calderwood SB; Harris JB
    Infect Immun; 2009 Sep; 77(9):3850-6. PubMed ID: 19528207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of human humoral responses after vaccination with a live attenuated V. cholerae vaccine.
    Adekunle O; Dretler A; Kauffman RC; Cho A; Rouphael N; Wrammert J
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009743. PubMed ID: 34478460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.
    Uddin T; Aktar A; Xu P; Johnson RA; Rahman MA; Leung DT; Afrin S; Akter A; Alam MM; Rahman A; Chowdhury F; Khan AI; Bhuiyan TR; Bufano MK; Rashu R; Yu Y; Wu-Freeman Y; Harris JB; LaRocque RC; Charles RC; Kováč P; Calderwood SB; Ryan ET; Qadri F
    Am J Trop Med Hyg; 2014 May; 90(5):873-81. PubMed ID: 24686738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection.
    Alam MM; Arifuzzaman M; Ahmad SM; Hosen MI; Rahman MA; Rashu R; Sheikh A; Ryan ET; Calderwood SB; Qadri F
    Clin Vaccine Immunol; 2013 Jan; 20(1):17-23. PubMed ID: 23114701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.
    Qadri F; Ahmed F; Karim MM; Wenneras C; Begum YA; Abdus Salam M; Albert MJ; McGhee JR
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):812-8. PubMed ID: 10548569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune mechanisms and protective antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development.
    Jonson G; Osek J; Svennerholm AM; Holmgren J
    Infect Immun; 1996 Sep; 64(9):3778-85. PubMed ID: 8751929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh.
    Rahman A; Rashu R; Bhuiyan TR; Chowdhury F; Khan AI; Islam K; LaRocque RC; Ryan ET; Wrammert J; Calderwood SB; Qadri F; Harris JB
    Clin Vaccine Immunol; 2013 Oct; 20(10):1592-8. PubMed ID: 23945156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.